Q32 Bio Inc. Share Price
QTTBQ32 Bio Inc. Stock Performance
Open $14.15 | Prev. Close $14.14 | Circuit Range N/A |
Day Range $12.32 - $14.20 | Year Range $1.34 - $14.70 | Volume 23,471 |
Average Traded $13.13 |
Q32 Bio Inc. Share Price Chart
About Q32 Bio Inc.
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.
Q32 Bio Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Jun-26 | $14.15 | $12.76 | +0.00% |
30-Jun-26 | $14.15 | $12.76 | -8.60% |
29-Jun-26 | $13.22 | $13.96 | +7.30% |
26-Jun-26 | $12.20 | $13.01 | +9.05% |
25-Jun-26 | $11.32 | $11.93 | +6.90% |
24-Jun-26 | $12.10 | $11.16 | -5.90% |
23-Jun-26 | $12.70 | $11.86 | -6.13% |